These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35726751)

  • 1. Anti-EBNA1 IgG titre is not associated with fatigue in multiple sclerosis patients.
    Fleischer M; Schuh H; Bickmann NM; Hagenacker T; Krüger K; Skripuletz T; Fiedler M; Kleinschnitz C; Pul R; Skuljec J
    Neurol Neurochir Pol; 2022; 56(3):236-245. PubMed ID: 35726751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review.
    Bose A; Khalighinejad F; Hoaglin DC; Hemond CC
    Mult Scler Relat Disord; 2024 Apr; 84():105410. PubMed ID: 38401201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.
    Persson Berg L; Thomsson E; Hasi G; Bäckström M; Bergström T
    J Virol Methods; 2020 Oct; 284():113927. PubMed ID: 32650039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
    Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-dose vitamin D
    Røsjø E; Lossius A; Abdelmagid N; Lindstrøm JC; Kampman MT; Jørgensen L; Sundström P; Olsson T; Steffensen LH; Torkildsen Ø; Holmøy T
    Mult Scler; 2017 Mar; 23(3):395-402. PubMed ID: 27325604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus in multiple sclerosis.
    Abdelrahman HS; Selim HS; Hashish MH; Sultan LI
    J Egypt Public Health Assoc; 2014 Aug; 89(2):90-5. PubMed ID: 25162741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus and Epstein-Barr virus infections in patients with neuromyelitis optica spectrum disorder.
    Shi Z; Kong L; Wang R; Wang X; Wang Z; Luo W; Chen H; Du Q; Sun D; Zhou H
    J Neurol; 2024 Sep; 271(9):6089-6095. PubMed ID: 39046523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.
    Dungan L; Dunne J; Savio M; Kalaszi M; McElheron M; Lynagh Y; O'Driscoll K; Roche C; Qureshi A; Crowley B; Conlon N; Kearney H
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200217. PubMed ID: 38547427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis.
    Comabella M; Tintore M; Sao Avilés A; Carbonell-Mirabent P; Malhotra S; Rovira A; Fissolo N; Lünemann JD; Montalban X
    J Neurol Neurosurg Psychiatry; 2023 Mar; 94(3):173-180. PubMed ID: 36344261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.